Publication | Closed Access

Analysis of time-to-treatment discontinuation of targeted therapy, immunotherapy, and chemotherapy in clinical trials of patients with non-small-cell lung cancer

Time-to-treatment DiscontinuationMedicineClinical TrialsBronchial NeoplasmImmune Checkpoint InhibitorTargeted TherapyCancer TreatmentImmunotherapyOncologyRadiation OncologyLung CancerRadiologyHealth Sciences